Accuracy of Serum Leucine-Rich Alpha-2 Glycoprotein in Evaluating Endoscopic Disease Activity in Crohn's Disease.

Tatsuya KawamuraTakeshi YamamuraMasanao NakamuraKeiko MaedaTsunaki SawadaEri IshikawaTadashi IidaYasuyuki MizutaniTakuya IshikawaNaomi KakushimaKazuhiro FurukawaEizaburo OhnoTakashi HondaHiroki KawashimaMasatoshi Ishigami

Published in: Inflammatory bowel diseases (2022)

Leucine-rich alpha-2 glycoprotein can be used in assessing endoscopic activity and is a reliable marker of endoscopic remission in CD patients. It can be an intermediate target in the treatment of CD.

Keyphrases

disease activity
ultrasound guided
rheumatoid arthritis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis
end stage renal disease
ejection fraction
newly diagnosed
nk cells
patient reported